X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-02-22 | TBPH | Farnum Rhonda | SVP, Comm, Medical Affairs | S - Sale | $8.71 | -1,254 | 311,733 | 0% | -$10,922 | ||||||
2023-11-21 | TBPH | Farnum Rhonda | SVP, Comm, Medical Affairs | S - Sale | $10.29 | -1,378 | 331,206 | 0% | -$14,180 | ||||||
2023-11-14 | TBPH | Graham Richard A | SVP, RESEARCH, DEVELOPMENT | S - Sale | $10.22 | -2,482 | 346,839 | -1% | -$25,366 | ||||||
2023-10-16 | TBPH | Graham Richard A | SVP, RESEARCH, DEVELOPMENT | S - Sale | $9.03 | -2,482 | 334,321 | -1% | -$22,412 | ||||||
2023-09-14 | TBPH | Graham Richard A | SVP, RESEARCH, DEVELOPMENT | S - Sale | $9.89 | -2,482 | 336,803 | -1% | -$24,547 | ||||||
2023-08-22 | TBPH | Farnum Rhonda | SVP, Comm, Medical Affairs | S - Sale | $9.47 | -1,807 | 340,566 | -1% | -$17,112 | ||||||
2023-08-11 | TBPH | Graham Richard A | SVP, RESEARCH, DEVELOPMENT | S - Sale | $9.99 | -2,322 | 349,746 | -1% | -$23,197 | ||||||
2023-07-14 | TBPH | Graham Richard A | SVP, RESEARCH, DEVELOPMENT | S - Sale | $9.84 | -2,322 | 352,068 | -1% | -$22,848 | ||||||
2023-06-14 | TBPH | Graham Richard A | SVP, RESEARCH, DEVELOPMENT | S - Sale | $10.69 | -2,322 | 354,390 | -1% | -$24,822 | ||||||
2023-06-08 | TBPH | Farnum Rhonda | SVP, Comm, Medical Affairs | S - Sale | $11.13 | -1,790 | 352,833 | -1% | -$19,923 | ||||||
2023-05-15 | TBPH | Graham Richard A | SVP, RESEARCH, DEVELOPMENT | S - Sale | $11.26 | -2,322 | 367,172 | -1% | -$26,146 | ||||||
2023-04-14 | TBPH | Graham Richard A | SVP, RESEARCH, DEVELOPMENT | S - Sale | $11.88 | -2,323 | 369,494 | -1% | -$27,597 | ||||||
2023-03-14 | TBPH | Graham Richard A | SVP, RESEARCH, DEVELOPMENT | S - Sale | $10.32 | -2,323 | 371,817 | -1% | -$23,973 | ||||||
2023-03-09 | TBPH | Farnum Rhonda | SVP, Comm, Medical Affairs | S - Sale | $10.20 | -4,000 | 360,190 | -1% | -$40,800 | ||||||
2023-03-06 | TBPH | Graham Richard A | SVP, RESEARCH, DEVELOPMENT | S - Sale | $10.05 | -2,323 | 374,140 | -1% | -$23,346 | ||||||
2022-12-14 | TBPH | Winningham Rick E | CEO | S - Sale | $11.19 | -50,000 | 1,443,364 | -3% | -$559,500 | ||||||
2022-12-01 | TBPH | Graham Richard A | SVP, RESEARCH, DEVELOPMENT | S - Sale | $10.73 | -2,084 | 313,520 | -1% | -$22,361 | ||||||
2022-11-18 | TBPH | Hindman Andrew A. | SVP, CFO | S - Sale | $11.02 | -65,000 | 384,714 | -14% | -$716,242 | ||||||
2022-08-16 | TBPH | Graham Richard A | SVP, Development | S - Sale | $9.71 | -4,906 | 364,745 | -1% | -$47,640 | ||||||
2022-08-09 | TBPH | Graham Richard A | SVP, Development | S - Sale | $8.79 | -15,086 | 369,651 | -4% | -$132,606 | ||||||
2022-05-23 | TBPH | Farnum Rhonda | SVP, Comm, Medical Affairs | S - Sale | $8.93 | -1,081 | 329,990 | 0% | -$9,653 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |